These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19766679)

  • 1. Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro--a quantitative study.
    Asgeirsdóttir SA; Talman EG; de Graaf IA; Kamps JA; Satchell SC; Mathieson PW; Ruiters MH; Molema G
    J Control Release; 2010 Jan; 141(2):241-51. PubMed ID: 19766679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexes.
    Leus NG; Talman EG; Ramana P; Kowalski PS; Woudenberg-Vrenken TE; Ruiters MH; Molema G; Kamps JA
    Int J Pharm; 2014 Jan; 459(1-2):40-50. PubMed ID: 24239833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression.
    Leus NG; Morselt HW; Zwiers PJ; Kowalski PS; Ruiters MH; Molema G; Kamps JA
    Int J Pharm; 2014 Jul; 469(1):121-31. PubMed ID: 24746643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo.
    Kowalski PS; Zwiers PJ; Morselt HW; Kuldo JM; Leus NG; Ruiters MH; Molema G; Kamps JA
    J Control Release; 2014 Feb; 176():64-75. PubMed ID: 24389338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-VCAM-1 and anti-E-selectin SAINT-O-Somes for selective delivery of siRNA into inflammation-activated primary endothelial cells.
    Kowalski PS; Lintermans LL; Morselt HW; Leus NG; Ruiters MH; Molema G; Kamps JA
    Mol Pharm; 2013 Aug; 10(8):3033-44. PubMed ID: 23819446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells.
    Kowalski PS; Kuninty PR; Bijlsma KT; Stuart MC; Leus NG; Ruiters MH; Molema G; Kamps JA
    Eur J Pharm Biopharm; 2015 Jan; 89():40-7. PubMed ID: 25460585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
    Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
    J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2.
    van der Gun BT; Monami A; Laarmann S; Raskó T; Slaska-Kiss K; Weinhold E; Wasserkort R; de Leij LF; Ruiters MH; Kiss A; McLaughlin PM
    J Control Release; 2007 Nov; 123(3):228-38. PubMed ID: 17884225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MC3/SAINT-O-Somes, a novel liposomal delivery system for efficient and safe delivery of siRNA into endothelial cells.
    He Y; Barlag M; Plantinga JA; Molema G; Kamps JAAM
    J Liposome Res; 2023 Dec; 33(4):328-337. PubMed ID: 36920318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VE-cadherin regulates migration inhibitory factor synthesis and release.
    Li R; Li L; Liu Y; Tang Y; Zhang R
    Inflamm Res; 2019 Oct; 68(10):877-887. PubMed ID: 31342095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells are susceptible to rapid siRNA transfection and gene silencing ex vivo.
    Andersen ND; Chopra A; Monahan TS; Malek JY; Jain M; Pradhan L; Ferran C; LoGerfo FW
    J Vasc Surg; 2010 Dec; 52(6):1608-15. PubMed ID: 20801607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice.
    Gutbier B; Kube SM; Reppe K; Santel A; Lange C; Kaufmann J; Suttorp N; Witzenrath M
    Pulm Pharmacol Ther; 2010 Aug; 23(4):334-44. PubMed ID: 20362688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial specific delivery of siRNA.
    Park K
    J Control Release; 2014 Feb; 176():133. PubMed ID: 24565023
    [No Abstract]   [Full Text] [Related]  

  • 14. siRNA knockdown of gene expression in endothelial cells.
    Dennstedt E; Bryan B
    Methods Mol Biol; 2011; 764():215-22. PubMed ID: 21748643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of short-interfering RNA silences adhesion molecule expression on cardiac microvascular cells.
    Walker T; Saup E; Nolte A; Simon P; Kornberger A; Steger V; Adolph O; Wendel HP
    Thorac Cardiovasc Surg; 2011 Sep; 59(6):322-8. PubMed ID: 21692023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing.
    Nolte A; Walker T; Schneider M; Kray O; Avci-Adali M; Ziemer G; Wendel HP
    Mol Med; 2011; 17(11-12):1213-22. PubMed ID: 21792480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells.
    Constantinescu CA; Fuior EV; Rebleanu D; Deleanu M; Simion V; Voicu G; Escriou V; Manduteanu I; Simionescu M; Calin M
    Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30669699
    [No Abstract]   [Full Text] [Related]  

  • 18. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
    Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
    Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective silencing of adhesion molecules on venous endothelial cells for protection of venous bypass grafts.
    Walker T; Müller I; Raabe C; Nohe B; Zanke C; Ziemer G; Wendel HP
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1241-7. PubMed ID: 21429759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.